Loading...
Akari Therapeutics, Plc
AKTX•NASDAQ
HealthcareBiotechnology
$1.42
$0.16(12.69%)
Akari Therapeutics, Plc (AKTX) Quarterly Earnings Reports & Financial Results
Analyze Akari Therapeutics, Plc’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of Akari Therapeutics, Plc’s actual vs. estimated earnings across recent quarters.
No data available
Akari Therapeutics, Plc (AKTX) Quarterly Earnings Details
Detailed breakdown of Akari Therapeutics, Plc’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.